De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Ind-Swift Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Ind-Swift Laboratories has a total shareholder equity of ₹9.3B and total debt of ₹166.2M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are ₹11.7B and ₹2.3B respectively. Ind-Swift Laboratories's EBIT is ₹1.4B making its interest coverage ratio 4.7. It has cash and short-term investments of ₹4.3B.
Belangrijke informatie
1.8%
Verhouding schuld/eigen vermogen
₹166.22m
Schuld
| Rente dekkingsratio | 4.7x |
| Contant | ₹4.32b |
| Aandelen | ₹9.31b |
| Totaal verplichtingen | ₹2.34b |
| Totaal activa | ₹11.65b |
Recente financiële gezondheidsupdates
Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly
Dec 28
These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well
Jul 22Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet
Jul 12These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively
Nov 11Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?
Jun 27Recent updates
Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Stock Rockets 29% But Many Are Still Ignoring The Company
Jul 02Shareholders In Ind-Swift Laboratories (NSE:INDSWFTLAB) Should Look Beyond Earnings For The Full Story
May 21Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Apr 13Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly
Dec 28These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well
Jul 22Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet
Jul 12Did Business Growth Power Ind-Swift Laboratories' (NSE:INDSWFTLAB) Share Price Gain of 231%?
Feb 17We're Not So Sure You Should Rely on Ind-Swift Laboratories's (NSE:INDSWFTLAB) Statutory Earnings
Dec 30These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively
Nov 11Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?
Jun 27Analyse van de financiële positie
Kortlopende schulden: INDSWFTLAB's short term assets (₹6.6B) exceed its short term liabilities (₹2.2B).
Langlopende schulden: INDSWFTLAB's short term assets (₹6.6B) exceed its long term liabilities (₹123.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: INDSWFTLAB has more cash than its total debt.
Schuld verminderen: INDSWFTLAB's debt to equity ratio has reduced from 191.9% to 1.8% over the past 5 years.
Schuldendekking: INDSWFTLAB's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: INDSWFTLAB's interest payments on its debt are well covered by EBIT (4.7x coverage).